LD-2 disclosure · 2nd Quarter - Report
ABBVIE INC.
via ABBVIE, INC.
Client
- Name
- ABBVIE INC.
- Location
- District of Columbia · United States of America
Registrant
- Firm
- ABBVIE, INC.
- Description
- Biopharmaceutical company
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
6 issuesCopyright/Patent/Trademark
S.1040, Drug Competition Enhancement Act Patent litigation reform issues and issues related to post-grant proceedings at the USPTO Value of intellectual property
LobbyistsSTEPHEN SCANGO · DANIEL BACHNER · DORCAS ADEKUNLE · CRYSTAL RILEY · RACHEL DERBY · GAVIN PROFFITT
Covered position (GAVIN PROFFITT): Professional Staff Member (6/2018-1/2020) for the House Republican Study Committee; Professional Staff member (2/2023-6/2025) for the House Committee on Energy and Commerce; Health Policy Advisor (6/2025-4/2026) for Senator Ron Johnson
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
S. 864, HELP Copays Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act S. 2903, Safe Step Act H.R. 5509, Safe Step Act Drug cost and pricing policy issues Patient affordability issues Issues related to the 340B program Issues related to data privacy Issues related to Hepatitis C elimination Issues related to FDA communications
LobbyistsSTEPHEN SCANGO · DANIEL BACHNER · DORCAS ADEKUNLE · CRYSTAL RILEY · RACHEL DERBY · GAVIN PROFFITT
Covered position (GAVIN PROFFITT): Professional Staff Member (6/2018-1/2020) for the House Republican Study Committee; Professional Staff member (2/2023-6/2025) for the House Committee on Energy and Commerce; Health Policy Advisor (6/2025-4/2026) for Senator Ron Johnson
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Management & Budget (OMB) · Health & Human Services, Dept of (HHS)